|
|
|
|
| LEADER |
00000cam a2200000Ii 4500 |
| 001 |
SCIDIR_ocn992119228 |
| 003 |
OCoLC |
| 005 |
20231120010205.0 |
| 006 |
m o d |
| 007 |
cr cnu|||unuuu |
| 008 |
170628s2017 ne ob 001 0 eng d |
| 010 |
|
|
|a 2016963526
|
| 040 |
|
|
|a N$T
|b eng
|e rda
|e pn
|c N$T
|d N$T
|d IDEBK
|d EBLCP
|d YDX
|d UIU
|d OPELS
|d GZM
|d MERER
|d UAB
|d STF
|d OCLCF
|d OCLCQ
|d ESU
|d UPM
|d OCLCQ
|d U3G
|d D6H
|d COS
|d COF
|d U3W
|d DEBBG
|d AU@
|d WYU
|d OCLCA
|d OCLCQ
|d LQU
|d DCT
|d ERF
|d OCLCQ
|d UKMGB
|d AUD
|d OCLCQ
|d OCLCO
|d S2H
|d OCLCO
|d LVT
|d VT2
|d OCLCO
|d OCLCQ
|d SFB
|d OCLCQ
|
| 066 |
|
|
|c (S
|
| 015 |
|
|
|a GBB766959
|2 bnb
|
| 016 |
7 |
|
|a 018299216
|2 Uk
|
| 019 |
|
|
|a 992265755
|a 992734972
|a 1066574643
|a 1105186754
|a 1105573974
|a 1229543371
|a 1235846802
|
| 020 |
|
|
|a 9780323527347
|q (electronic bk.)
|
| 020 |
|
|
|a 0323527345
|q (electronic bk.)
|
| 020 |
|
|
|z 9780323527330
|
| 020 |
|
|
|z 0323527337
|
| 024 |
0 |
|
|a 40027455223
|
| 035 |
|
|
|a (OCoLC)992119228
|z (OCoLC)992265755
|z (OCoLC)992734972
|z (OCoLC)1066574643
|z (OCoLC)1105186754
|z (OCoLC)1105573974
|z (OCoLC)1229543371
|z (OCoLC)1235846802
|
| 050 |
|
4 |
|a RM267
|
| 072 |
|
7 |
|a MED
|x 071000
|2 bisacsh
|
| 082 |
0 |
4 |
|a 615.329
|2 23
|
| 245 |
0 |
0 |
|a Antimicrobial nanoarchitectonics :
|b from synthesis to applications /
|c edited by Alexandru Mihai Grumezescu.
|
| 264 |
|
1 |
|a Amsterdam, Netherlands :
|b Elsevier,
|c [2017]
|
| 300 |
|
|
|a 1 online resource
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 500 |
|
|
|a Includes index.
|
| 588 |
0 |
|
|a Vendor-supplied metadata.
|
| 505 |
0 |
|
|6 880-01
|a Cover; Title Page; Copyright Page; Contents; List of Contributors; Foreword; Preface; Chapter 1 -- New Trends in the Antimicrobial Agents Delivery Using Nanoparticles; 1 -- Introduction; 2 -- Nanoparticles for drug-delivery systems; 3 -- Polymeric carriers used to prepare nanoparticles as drug carriers; 3.1 -- Natural Polymers; 3.1.1 -- Alginates; 3.1.2 -- Chitosan; 3.1.3 -- Gelatin; 3.2 -- Semisynthetic Polymers; 3.3 -- Synthetic Biodegradable Polymers; 3.3.1 -- Poly(esters); 3.3.2 -- Poly(anhydrides); 3.3.3 -- Poly-[epsilon]-Caprolactones; 3.3.4 -- Poly(orthoesters)
|
| 505 |
8 |
|
|a 5.1.2.1 -- Aluminium oxide nanoparticles5.1.2.2 -- Magnesium oxide nanoparticles; 5.1.2.3 -- Copper oxide nanoparticles; 5.1.2.4 -- Zinc oxide nanoparticles; 5.1.2.5 -- Titanium dioxide nanoparticles; 5.1.2.6 -- Nitric oxide nanoparticles; 5.1.2.7 -- Iron oxide; 5.2 -- Organic Nanoparticles; 5.2.1 -- Poly-[epsilon]-lysine; 5.2.2 -- Triclosan; 5.2.3 -- Quaternary Ammonium Compounds; 5.2.4 -- Polyethyleneimine; 5.2.5 -- Cationic Quaternary Polyelectrolytes; 5.2.6 -- N-Halamine compounds; 5.2.7 -- Polysiloxanes; 5.2.8 -- Benzoic Acid, Phenol, and P-Hydroxy Benzoate Esters; 5.2.9 -- Benzaldehyde
|
| 505 |
8 |
|
|a 4 -- Recent trends in nanoparticulate drug-delivery systems4.1 -- Biological Transport of Nanoparticles; 4.2 -- Ideal Properties of Nanoparticle Delivery Systems; 4.3 -- Types of Nanoparticulate Drug Delivery System; 4.3.1 -- Polymeric Micelles; 4.3.2 -- Microemulsion; 4.3.3 -- Liposomes; 4.3.4 -- Solid Lipid Nanoparticles; 4.3.5 -- Lipid Nanocapsules; 4.3.6 -- Dendrimers; 4.3.7 -- Chitosan-Based Nanoparticulate; 5 -- Application of nanoparticles/diverse and emerging trends in nanoparticles applications; 6 -- Concluding remarks and future prospects; References
|
| 505 |
8 |
|
|a Chapter 2 -- Nanostructures as Antimicrobial Therapeutics1 -- Introduction; 2 -- Nanoparticles as antimicrobial agents; 2.1 -- What Are Nanostructures?; 2.2 -- Distinctive Properties of Nanoparticles; 2.2.1 -- Appropriate Size; 2.2.2 -- Surface Chemistry (Functionalizable Structure); 2.2.3 -- Chemical Stability; 2.2.4 -- High Surface Area to Mass Ratio; 2.2.5 -- High Reactivity; 2.2.6 -- Biosafety and Biocompatibility; 3 -- Mode of action of nanoparticles; 3.1 -- Cell Membrane Damage; 3.2 -- Release of Toxic Ions; 3.3 -- Interruption of Electron Transport, Protein Oxidation, and Membrane Collapse
|
| 505 |
8 |
|
|a 3.4 -- Generation of Reactive Oxygen Species (ROS)3.5 -- Photothermal Damage; 4 -- Nanoparticles use in antimicrobial therapy; 4.1 -- As Conjugates to Enhance Activity of Already Existing Antibiotics; 4.2 -- As Antimicrobial Agents; 4.3 -- As Encapsulating Agents for Efficient Drug Delivery; 4.4 -- For Surface Coating in Medical Devices; 4.5 -- As Antimicrobial Nanovaccines; 4.5.1 -- Nanoparticles for Vaccine Delivery; 4.5.2 -- Nanoadjuvants; 5 -- Types of nanoparticles; 5.1 -- Inorganic; 5.1.1 -- Metals; 5.1.1.1 -- Silver nanoparticles; 5.1.1.2 -- Gold nanoparticles; 5.1.2 -- Metal Oxide Nanoparticles
|
| 505 |
8 |
|
|a 5.2.10 -- Quaternary Phosphonium or Sulfonium Groups
|
| 504 |
|
|
|a Includes bibliographical references and index.
|
| 650 |
|
0 |
|a Anti-infective agents.
|
| 650 |
|
0 |
|a Nanostructured materials.
|
| 650 |
|
2 |
|a Anti-Infective Agents
|0 (DNLM)D000890
|
| 650 |
|
2 |
|a Nanostructures
|0 (DNLM)D049329
|
| 650 |
|
6 |
|a Antiinfectieux.
|0 (CaQQLa)201-0001694
|
| 650 |
|
6 |
|a Nanomat�eriaux.
|0 (CaQQLa)201-0258061
|
| 650 |
|
7 |
|a MEDICAL
|x Pharmacology.
|2 bisacsh
|
| 650 |
|
7 |
|a Anti-infective agents.
|2 fast
|0 (OCoLC)fst00810345
|
| 650 |
|
7 |
|a Nanostructured materials.
|2 fast
|0 (OCoLC)fst01032630
|
| 700 |
1 |
|
|a Grumezescu, Alexandru Mihai,
|e editor.
|
| 776 |
0 |
8 |
|i Print version:
|t Antimicrobial nanoarchitectonics.
|d Amsterdam, Netherlands : Elsevier, [2017]
|z 9780323527330
|z 0323527337
|w (OCoLC)960845576
|
| 856 |
4 |
0 |
|u https://sciencedirect.uam.elogim.com/science/book/9780323527330
|z Texto completo
|
| 880 |
8 |
|
|6 505-00/(S
|a 5.1.2.1 -- Aluminium oxide nanoparticles5.1.2.2 -- Magnesium oxide nanoparticles; 5.1.2.3 -- Copper oxide nanoparticles; 5.1.2.4 -- Zinc oxide nanoparticles; 5.1.2.5 -- Titanium dioxide nanoparticles; 5.1.2.6 -- Nitric oxide nanoparticles; 5.1.2.7 -- Iron oxide; 5.2 -- Organic Nanoparticles; 5.2.1 -- Poly-ε-lysine; 5.2.2 -- Triclosan; 5.2.3 -- Quaternary Ammonium Compounds; 5.2.4 -- Polyethyleneimine; 5.2.5 -- Cationic Quaternary Polyelectrolytes; 5.2.6 -- N-Halamine compounds; 5.2.7 -- Polysiloxanes; 5.2.8 -- Benzoic Acid, Phenol, and P-Hydroxy Benzoate Esters; 5.2.9 -- Benzaldehyde
|
| 880 |
0 |
|
|6 505-01/(S
|a Cover; Title Page; Copyright Page; Contents; List of Contributors; Foreword; Preface; Chapter 1 -- New Trends in the Antimicrobial Agents Delivery Using Nanoparticles; 1 -- Introduction; 2 -- Nanoparticles for drug-delivery systems; 3 -- Polymeric carriers used to prepare nanoparticles as drug carriers; 3.1 -- Natural Polymers; 3.1.1 -- Alginates; 3.1.2 -- Chitosan; 3.1.3 -- Gelatin; 3.2 -- Semisynthetic Polymers; 3.3 -- Synthetic Biodegradable Polymers; 3.3.1 -- Poly(esters); 3.3.2 -- Poly(anhydrides); 3.3.3 -- Poly-ε-Caprolactones; 3.3.4 -- Poly(orthoesters)
|
